Acute Coronary Syndromes
OUP Oxford, Oct 23, 2008 - Medical - 100 pages
Coronary artery disease is the most common cause of morbidity in the developed and developing world. In the acute situation, in contrast to the stable presentation, there is a need for urgency with clear benefits from intervention. However it is imperative that risks are assessed and addressed as part of the long term strategy. Preventing acute coronary syndromes is more important than dealing with them. This concise, practical pocketbook opens with the background and mechanisms leading to the acute event and how an understanding of the pathophysiology can direct the overall management and not just the acute presentation. The books intention is to highlight the practical aspects of management and establish straightforward management plans. It therefore looks at the syndromes via a team approach to address all of the issues and optimise care.
What people are saying - Write a review
We haven't found any reviews in the usual places.
2 Pathophysiology of acute coronary syndromes
3 Prevention of acute coronary syndromes
4 Initial evaluation
5 Initial management
6 Subsequent management
ACE inhibitors acute coronary syndromes acute myocardial infarction admission angiography anti-platelet aspirin associated atherosclerotic benefit beta-blockers blockers blood pressure cardiac rehabilitation cardiogenic shock Cardiology cardiovascular disease cardiovascular events cardiovascular risk cent reduction CHD events chest pain cholesterol Circulation clinical clopidogrel complications coronary artery disease coronary disease coronary events coronary heart disease death diagnosis discharge dose drugs dysrhythmias effects electrocardiogram EnglJ exercise fibrous cap follow-up Framingham guidelines haemodynamic heart failure heparin high-risk hospital hypertension improved increased intravenous ischaemia ischaemic Lancet LDL-C left ventricular lesions lifestyle lipid mmHg mmol/L mortality muscle necrotic core obesity Optimal outcome oxygen patients with acute percutaneous coronary intervention plaque rupture platelet post-MI primary prognostic randomized receptor recurrent reduced reduction in CHD revascularization risk factors secondary prevention ST-elevation ST-segment elevation statins stent symptoms systolic therapy thrombolysis thrombus tion treatment trial troponin Type 2 diabetes unstable angina vessel VSMCs